ATRC
AtriCure Inc
NASDAQ: ATRC · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$28.11
+2.82% today
Updated 2026-04-30
Market cap
$1.38B
P/E ratio
—
P/S ratio
2.59x
EPS (TTM)
$-0.24
Dividend yield
—
52W range
$27 – $43
Volume
0.7M
AtriCure Inc (ATRC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$28.11
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$79.30
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.3B | $0.3B | $0.4B | $0.5B | $0.5B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -2.14%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.